06/02/2025
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
4:24 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
05/28/2025
4:20 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:36 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B5 | |
04/10/2025
4:28 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SCHEDULE 13G/A | |
03/30/2025
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
03/28/2025
3:44 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B3 | |
03/12/2025
8:11 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/12/2025
7:56 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4/A | |
03/09/2025
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
02/28/2025
3:37 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for OTLK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
7:17 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
3:38 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:14 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
3:16 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
02/10/2025
3:19 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form ARS | |
02/06/2025
3:40 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:46 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form PRE 14A | |
01/31/2025
3:39 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
4:04 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/23/2025
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 10-K/A | |
01/22/2025
3:17 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
01/16/2025
4:16 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
3:30 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/27/2024
7:14 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:11 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:27 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
11:26 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:55 PM | GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SC 13G/A | |
10/03/2024
8:22 PM | Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:53 PM | KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:48 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
7:41 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
6:25 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
Buy OTLK Stock Free OTLK Stock Alerts